Lauren D'Angelo Biography and Net Worth

COO of Alpha Cognition

Ms. D'Angelo brings 25 years in pharmaceuticals marketing, sales, and operations, with broad reaching clinical experience across 15 products within nine therapeutic areas. She has deep experience in small and large organizations from pre-commercialization to launch and post-launch, with demonstrated success building commercialization and launch plans for US and global markets, and managing P&L. She has developed and led 20+ launch plans and successfully launched 16 products, new indications, and line extensions, in varying leadership roles. She was recognized as a 2025 LifeSci Voice Top Industry Leader, 2023 PharmaVoice Top 100 Industry Leader, Medical Marketing & Media's (MM+M) 2022 Woman of Distinction, MM+M's 2017 Woman to Watch, and was selected as one of Pharmaceutical Executive's Emerging Pharma Leaders for 2020.

What is Lauren D'Angelo's net worth?: The estimated net worth of Lauren D'Angelo is at least $1.11 million as of May 19th, 2026. Ms. D'Angelo owns 140,695 shares of Alpha Cognition stock worth more than $1,108,114 as of July 24th. This net worth estimate does not reflect any other assets that Ms. D'Angelo may own. Learn More about Lauren D'Angelo's net worth.
How do I contact Lauren D'Angelo?: The corporate mailing address for Ms. D'Angelo and other Alpha Cognition executives is 20073 FIDDLERS GREEN, FRISCO, TX, 75036. Alpha Cognition can also be reached via phone at (858) 344-4375 and via email at [email protected]. Learn More on Lauren D'Angelo's contact information.
Has Lauren D'Angelo been buying or selling shares of Alpha Cognition?: Lauren D'Angelo has not been actively trading shares of Alpha Cognition during the past quarter. Most recently, on Tuesday, May 19th, Lauren D'angelo bought 3,500 shares of Alpha Cognition stock. The stock was acquired at an average cost of $5.76 per share, with a total value of $20,160.00. Following the completion of the transaction, the chief operating officer now directly owns 140,695 shares of the company's stock, valued at $810,403.20. Learn More on Lauren D'Angelo's trading history.
Are insiders buying or selling shares of Alpha Cognition?: In the last year, Alpha Cognition insiders bought shares 2 times. They purchased a total of 18,500 shares worth more than $147,510.00. In the last year, insiders at the sold shares 1 times. They sold a total of 27,778 shares worth more than $250,002.00. The most recent insider tranaction occured on May, 19th when COO Lauren D'angelo bought 3,500 shares worth more than $20,160.00. Insiders at Alpha Cognition own 8.6% of the company. Learn More about insider trades at Alpha Cognition.
Information on this page was last updated on 5/19/2026.

Lauren D'Angelo Insider Trading History at Alpha Cognition

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/19/2026	Buy	3,500	$5.76	$20,160.00	140,695

Lauren D'Angelo Buying and Selling Activity at Alpha Cognition

Alpha Cognition Company Overview

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Today's Range

Now: $8.00

$7.60

$8.48

50 Day Range

MA: $6.87

$5.73

$8.52

2 Week Range

Now: $8.00

$4.50

$10.15

Volume

23,544 shs

Average Volume

61,836 shs

Market Capitalization

$174.14 million

P/E Ratio

N/A

Dividend Yield